Neuren Pharmaceuticals | NEU - Gross Profit On Sales

Stock Price
13.05
Daily Change
-0.39 -2.90%
Monthly
-23.68%
Yearly
-1.36%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD6.69M in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 49.21M 13.25M Mar/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.95M 1.18M Jun/2025
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Dianthus Therapeutics USD 396K 203K Sep/2025
Genetic Signatures AUD 4.75M 190K Dec/2024
Ionis Pharmaceuticals USD 195M 40M Dec/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Organon & Co USD 854M 3M Dec/2025
Paradigm Biopharmaceuticals AUD -9K 423.94K Jun/2025
PYC Therapeutics AUD 5.83M 750K Jun/2025
Starpharma Holdings AUD -736K 2.82M Jun/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Telix Pharmaceuticals AUD 217.82M 9.23M Dec/2025
Viatris USD 1.15B 223.6M Dec/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025